Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernanda Amary

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
The American Journal of Surgical Pathology|May 16, 2017
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of BoneFernanda Amary, Fitim Berisha, Hongtao Ye, et al.
Skeletal Radiology|December 26, 2025
Expanding the differential diagnosis of bone-forming tumors: a new entity characterized by a NIPBL::BEND2 fusionDanielle Forster, Rashed Al-Khudairi, Fiona Bonar, et al.
The Journal of Pathology. Clinical Research|May 10, 2021
MYC amplifications are common events in childhood osteosarcomaSolange De Noon, Jannat Ijaz, Tim Hh Coorens, et al.
The American Journal of Surgical Pathology|August 30, 2022
Brown Tumors Belong to the Spectrum of KRAS -driven NeoplasmsDaniel Turek, Simon Haefliger, Baptiste Ameline, et al.
Histopathology|November 15, 2011
IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromasStephen Damato, Mohammed Alorjani, Fiona Bonar, et al.
Journal of Clinical Pathology|February 14, 2018
HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics CommitteeNewton A C S Wong, Fernanda Amary, Rachel Butler, et al.
Head and Neck Pathology|June 26, 2021
Ossifying Fibroma of Non-odontogenic Origin: A Fibro-osseous Lesion in the Craniofacial Skeleton to be (Re-)consideredDaniel Baumhoer, Simon Haefliger, Baptiste Ameline, et al.
Geroscience|June 16, 2024
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implicationsSimon Haefliger, Olga Chervova, Christopher Davies, et al.
The American Journal of Surgical Pathology|September 7, 2019
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic ToolFernanda Amary, Eva Markert, Fitim Berisha, et al.
The Journal of Pathology|June 14, 2023
Subclassification of epithelioid sarcoma with potential therapeutic impactSimon Haefliger, Olga Chervova, Christopher Davies, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|May 16, 2017
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of BoneFernanda Amary, Fitim Berisha, Hongtao Ye, et al.
Skeletal Radiology|December 26, 2025
Expanding the differential diagnosis of bone-forming tumors: a new entity characterized by a NIPBL::BEND2 fusionDanielle Forster, Rashed Al-Khudairi, Fiona Bonar, et al.
The Journal of Pathology. Clinical Research|May 10, 2021
MYC amplifications are common events in childhood osteosarcomaSolange De Noon, Jannat Ijaz, Tim Hh Coorens, et al.
The American Journal of Surgical Pathology|August 30, 2022
Brown Tumors Belong to the Spectrum of KRAS -driven NeoplasmsDaniel Turek, Simon Haefliger, Baptiste Ameline, et al.
Histopathology|November 15, 2011
IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromasStephen Damato, Mohammed Alorjani, Fiona Bonar, et al.
Journal of Clinical Pathology|February 14, 2018
HER2 testing of gastro-oesophageal adenocarcinoma: a commentary and guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics CommitteeNewton A C S Wong, Fernanda Amary, Rachel Butler, et al.
Head and Neck Pathology|June 26, 2021
Ossifying Fibroma of Non-odontogenic Origin: A Fibro-osseous Lesion in the Craniofacial Skeleton to be (Re-)consideredDaniel Baumhoer, Simon Haefliger, Baptiste Ameline, et al.
Geroscience|June 16, 2024
Epigenetic age acceleration is a distinctive trait of epithelioid sarcoma with potential therapeutic implicationsSimon Haefliger, Olga Chervova, Christopher Davies, et al.
The American Journal of Surgical Pathology|September 7, 2019
FOS Expression in Osteoid Osteoma and Osteoblastoma: A Valuable Ancillary Diagnostic ToolFernanda Amary, Eva Markert, Fitim Berisha, et al.
The Journal of Pathology|June 14, 2023
Subclassification of epithelioid sarcoma with potential therapeutic impactSimon Haefliger, Olga Chervova, Christopher Davies, et al.
Pageof 8